Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Calmodulin 2 pseudogene 3 (CALM2P3) is a processed or unprocessed pseudogene found in the human genome. It is related to the calmodulin 2 gene (CALM2), which encodes a highly conserved calcium-binding messenger protein involved in diverse cellular signaling and is linked to cardiac function, cancer, and other processes[1][2][4]. However, CALM2P3 itself does not encode a protein and has no documented biological or clinical function. Pseudogenes like CALM2P3 serve primarily as genomic relics but can sometimes influence regulation of their parent genes via RNA-based mechanisms; no such effect is assigned to CALM2P3 in current scientific databases or literature[1][2][5]. In summary, CALM2P3 is a non-functional pseudogene, not a valid therapeutic target, and provides no gainful structured drug development data. Only functional genes such as CALM2 (calmodulin 2), not their pseudogenes, serve as legitimate molecular targets in pharmacology or molecular biology[1][2][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Calmodulin 2 pseudogene 3 (CALM2P3).